Published: October 3, 2018
Categorised in: In the House
42nd Parliament, 1st Session
Sponsored by MP Julian and initiated by James OHara, Executive Director, Canadians for Fair Access to Medical Marijuana (CFAMM). CFAMM is a national non-profit organization that represents medical cannabis patients’ rights.
The Petition is open for signature until January 31, 2019, at 2:27 p.m. (EDT)
Petition to the House of Commons
Health care is a human right and no Canadian should be denied access to prescription medicine they need to be healthy;
A “medical cannabis product” is a cannabis product sold for medical purposes pursuant to a licence for the sale of cannabis for medical purposes granted in accordance with the Controlled Drugs and Substances Act or the Cannabis Act;
Although medical cannabis does not have a Drug Identification Number (DIN), it is produced and sold in a highly regulated regime;
Patients who are legally authorized/prescribed cannabis for medical purposes can legally purchase quality-controlled cannabis for medical purposes from a Health Canada licensed producer;
The Canada Revenue Agency considers cannabis for medical purposes a tax-deductible medical expense; and
The Government of Canada allows for reasonable access to medical cannabis for all Canadians who have been authorized to use it by a health-care practitioner.
We, the undersigned, residents and citizens of Canada, call upon the House of Commons to:
1. Support Motion M-198 and reverse its decision to apply an excise duty to cannabis sold for medical purposes;
2. Recognize that cannabis for medical purposes should be exempt from any taxes, including the new excise tax, after the passage of Bill C-74;
3. Zero-rate the medical cannabis tax in line with all other prescription medicines; and
4. Exempt medical cannabis products from any additional taxes in order to allow for reasonable access to medical cannabis for all Canadians authorized to use it by a health-care practitioner.
About Petitions and how they work: petitions.ourcommons.ca/en/Home/About« Back to News